Wisconsin startup testing shelved Bristol-Myers Squibb cancer drug tanespimycin
The company's lead drug, Triolimus, received FDA orphan designation last April.
co-d therapuetics
The company's lead drug, Triolimus, received FDA orphan designation last April.